0 40 eps expected for heska corporation hska 4

$0.40 EPS Expected for Heska Corporation (HSKA)

May 3, 2018 – By Linda Rogers

Investors sentiment decreased to 0.77 in 2017 Q4. Its down 0.49, from 1.26 in 2017Q3. It turned negative, as 20 investors sold Heska Corporation shares while 51 reduced holdings. 21 funds opened positions while 34 raised stakes. 5.99 million shares or 8.21% more from 5.53 million shares in 2017Q3 were reported.

Albion Gp Ut invested 0.08% of its portfolio in Heska Corporation (NASDAQ:HSKA). The New York-based Bnp Paribas Arbitrage Sa has invested 0% in Heska Corporation (NASDAQ:HSKA). Parallax Volatility Advisers Lp holds 0% or 966 shares. Parkside State Bank Tru holds 0% or 27 shares in its portfolio. Ativo Cap Mgmt Limited Liability Co holds 0.24% of its portfolio in Heska Corporation (NASDAQ:HSKA) for 11,003 shares. Guggenheim Capital Lc has 0% invested in Heska Corporation (NASDAQ:HSKA) for 14,593 shares. Thrivent Financial For Lutherans reported 93,910 shares stake. 20,162 are owned by Kbc Nv. 5,217 were accumulated by American International Gp. Teachers Retirement Of The State Of Kentucky holds 2,900 shares or 0% of its portfolio. Moreover, Victory Cap Inc has 0% invested in Heska Corporation (NASDAQ:HSKA). California Employees Retirement System has invested 0% of its portfolio in Heska Corporation (NASDAQ:HSKA). Ftb Advisors Inc owns 53 shares for 0% of their portfolio. 4,403 were reported by State Teachers Retirement. Martingale Asset Limited Partnership invested in 0.01% or 13,303 shares.

Analysts expect Heska Corporation (NASDAQ:HSKA) to report $0.40 EPS on May, 4 before the open.They anticipate $0.21 EPS change or 34.43 % from last quarter’s $0.61 EPS. HSKA’s profit would be $2.97 million giving it 53.27 P/E if the $0.40 EPS is correct. After having $0.63 EPS previously, Heska Corporation’s analysts see -36.51 % EPS growth. The stock increased 3.10% or $2.56 during the last trading session, reaching $85.23. About 93,019 shares traded. Heska Corporation (NASDAQ:HSKA) has declined 19.59% since May 3, 2017 and is downtrending. It has underperformed by 31.14% the S&P500.

Heska Corporation (NASDAQ:HSKA) Ratings Coverage

Among 2 analysts covering Heska Corp (NASDAQ:HSKA), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Heska Corp had 2 analyst reports since December 4, 2017 according to SRatingsIntel. B. Riley & Co maintained Heska Corporation (NASDAQ:HSKA) on Thursday, March 1 with “Neutral” rating.

Heska Corporation develops, manufactures, and markets advanced veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Europe, and internationally. The company has market cap of $633.05 million. It operates through two divisions, Core Companion Animal Health; and Other Vaccines, Pharmaceuticals and Products. It has a 65.56 P/E ratio. The Core Companion Animal Health segment offers Element DC and DRI-CHEM 7000 veterinary chemistry analyzers for blood chemistry and electrolyte analysis; HT5 and HEMATRUE veterinary hematology analyzers to measure white and red blood cell count, platelet count, and hemoglobin levels in animals; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and IV pumps.

Heska Corporation (NASDAQ:HSKA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Back To Top